Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew James

Showing results (521-530 of 528) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 528 results.
The Lancet. Oncology|April 15, 2024
[<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trialLouise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X<sub>L</sub> InhibitorLe Wang, George A Doherty, Andrew S Judd, et al.
The Lancet. Oncology|February 16, 2025
Overall survival and quality of life with [<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trialLouise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
International Journal of Surgery (London, England)|November 14, 2021
STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgeryGinimol Mathew, Riaz Agha, Joerg Albrecht, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort studyTanya I Coulter, Anita Chandra, Chris M Bacon, et al.
Nature Methods|May 12, 2025
A universal language for finding mass spectrometry data patternsTito Damiani, Alan K Jarmusch, Allegra T Aron, et al.
The Bone & Joint Journal|March 1, 2024
The characteristics and predictors of mortality in periprosthetic fractures around the kneeAhmed A H H Nasser, Manpreet Sidhu, Rohan Prakash, et al.
Injury|November 8, 2023
Predictors of mortality in periprosthetic fractures of the hip: Results from the national PPF studyAhmed Abdul Hadi Harb Nasser, Rohan Prakash, Charles Handford, et al.
Pageof 53

Showing results (521-530 of 528) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 528 results.
The Lancet. Oncology|April 15, 2024
[<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trialLouise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X<sub>L</sub> InhibitorLe Wang, George A Doherty, Andrew S Judd, et al.
The Lancet. Oncology|February 16, 2025
Overall survival and quality of life with [<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trialLouise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
International Journal of Surgery (London, England)|November 14, 2021
STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgeryGinimol Mathew, Riaz Agha, Joerg Albrecht, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort studyTanya I Coulter, Anita Chandra, Chris M Bacon, et al.
Nature Methods|May 12, 2025
A universal language for finding mass spectrometry data patternsTito Damiani, Alan K Jarmusch, Allegra T Aron, et al.
The Bone & Joint Journal|March 1, 2024
The characteristics and predictors of mortality in periprosthetic fractures around the kneeAhmed A H H Nasser, Manpreet Sidhu, Rohan Prakash, et al.
Injury|November 8, 2023
Predictors of mortality in periprosthetic fractures of the hip: Results from the national PPF studyAhmed Abdul Hadi Harb Nasser, Rohan Prakash, Charles Handford, et al.
Pageof 53